Reference
Narasimhalu K, et al. Cost Effectiveness of Genotype-Guided Antiplatelet Therapy in Asian Ischemic Stroke Patients: Ticagrelor as an Alternative to Clopidogrel in Patients with CYP2C19 Loss of Function Mutations. Clinical Drug Investigation : 21 Sep 2020. Available from: URL: https://doi.org/10.1007/s40261-020-00970-y
Rights and permissions
About this article
Cite this article
Genotype-guided ticagrelor cost effective for stroke prevention in Asians. PharmacoEcon Outcomes News 863, 16 (2020). https://doi.org/10.1007/s40274-020-7170-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-020-7170-1